Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Bioconjugate chemistry

• Publication date

  2004-04-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC034208WPMID 15149184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

  2003cited by this paper
• Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.

  2003cited by this paper
• N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.

  2003cited by this paper
• Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.

  2002cited by this paper
• Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide.

  2002cited by this paper
• Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.

  2001cited by this paper
• Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.

  2000cited by this paper
• Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.

  2000cited by this paper
• Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-d-Phe1-octreotide

  2000cited by this paper
• Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence

  1999cited by this paper
• Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

  1999cited by this paper
• A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.

  1999cited by this paper
• Ontogeny and species differences in the pancreatic expression and localization of the CCK(A) receptors.

  1999cited by this paper
• Synthesis of stable hydrazones of a hydrazinonicotinyl-modified peptide for the preparation of 99mTc-labeled radiopharmaceuticals.

  1999cited by this paper
• 99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution.

  1999cited by this paper
• Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.

  1999cited by this paper
• Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

  1999cited by this paper
• Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

  1998cited by this paper
• Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.

  1998cited by this paper
• Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.

  1997cited by this paper
• Endocytosis of gastrin in cancer cells expressing gastrin/CCK-B receptor

  1997cited by this paper
• Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

  1997cited by this paper
• Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.

  1996cited by this paper
• Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human.

  1994cited by this paper
• Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins.

  1993cited by this paper
• Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

  1990cited by this paper

• Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors

  2025cites this paper
• Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy

  2024cites this paper
• Effect of Tin(II) Chloride Amount on 99mTc-Labeling of One 6-Hydrazinonicotinamide-Conjugated Peptide in the Presence of Tricine/Nicotinic Acid

  2022cites this paper
• Downregulation of CCKBR Expression Inhibits the Proliferation of Gastric Cancer Cells, Revealing a Potential Target for Immunotoxin Therapy.

  2022cites this paper
• Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities.

  2021cites this paper
• Study the 99m Tc-labeling conditions of HYNIC-conjugated peptides from a new perspective: Introduction to the term radio-stoichiometry.

  2020cites this paper
• Cholecystokinin-2 receptor targeting with radiolabeled peptides: current status and future directions.

  2020cites this paper
• Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging.

  2020cites this paper
• Elucidating the Structure-Activity Relationship of the Pentaglutamic Acid Sequence of Minigastrin with Cholecystokinin Receptor Subtype 2.

  2019cites this paper
• Correlation between in vitro and in vivo data of radiolabeled peptide for tumor targeting.

  2019cites this paper
• Tumor targeting with 99mTc radiolabeled peptides: Clinical application and recent development

  2018cites this paper
• Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor

  2018cites this paper
• sCCK8 Analogues for Targeting CCK2-Receptor Positive Tumors: Synthesis and Evaluation

  2018cites this paper
• Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue

  2016cites this paper
• Radiolabeled Agents for Molecular Imaging and/or Therapy

  2016cites this paper
• Liposomal doxorubicin doubly functionalized with CCK8 and R8 peptide sequences for selective intracellular drug delivery

  2015cites this paper
• Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptor.

  2015cites this paper
• Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection

  2015cites this paper
• Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting.

  2015cites this paper
• Radiolabelled peptides for oncological diagnosis

  2012cites this paper
• Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer

  2012cites this paper
• Radiopharmaceutical development of radiolabelled peptides

  2012cites this paper
• In Vitro and In Vivo Characterization of Three 68Ga- and 111In-Labeled Peptides for Cholecystokinin Receptor Imaging

  2012cites this paper
• Chelating systems for (99m)Tc/(188)Re in the development of radiolabeled peptide pharmaceuticals.

  2012cites this paper
• Radiometallated peptides for molecular imaging and targeted therapy.

  2011cites this paper
• Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides

  2011cites this paper
• Application of a validated stability-indicating chromatographic method to evaluate the reproducibility between batches of small peptides in solution.

  2010cites this paper
• Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

  2010cites this paper
• Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting.

  2010cites this paper
• Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.

  2010cites this paper
• (99m)Tc-radiolabelled peptides for tumour imaging: present and future.

  2010cites this paper
• Molecular imaging targeting peptide receptors.

  2009cites this paper
• Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

  2009cites this paper
• Peptides for tumour therapy and diagnosis: current status and future directions.

  2009cites this paper
• Targeting of a CCK2 receptor splice variant with 111In-labelled cholecystokinin-8 (CCK8) and 111In-labelled minigastrin

  2008cites this paper
• Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.

  2008cites this paper
• Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.

  2008cites this paper
• Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.

  2008cites this paper
• and 111 In-labelled minigastrin

  2008cites this paper
• In vivo and in vitro characterization of CCK8 bearing a histidine‐based chelator labeled with 99mTc‐tricarbonyl

  2008cites this paper
• The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin‐8 (CCK8) peptide for CCK‐2 receptors imaging: in vitro and in vivo studies

  2007cites this paper
• CCK receptors and cancer.

  2007cites this paper
• Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.

  2007cites this paper
• Targeting CCK receptors in human cancers.

  2007cites this paper
• 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours

  2007cites this paper
• Entwicklung neuer rezeptorgesteuerter Radiopharmazeutika für die Therapie von malignen Hirntumoren und medullären Schilddrüsenkarzinomen

  2006cites this paper
• 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.

  2006cites this paper
• Cholecystokinin and gastrin receptors.

  2006cites this paper
• Evaluation of Cholecystokinin (CCK-8) Peptide Thermal Stability for Use as Radiopharmaceutical by Means Isothermal and Nonisothermal Approaches

  2006cites this paper
• The direct route may not be the best way to home.

  2005cites this paper
• Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.

  2005cites this paper
• 29 Metal complexes as pharmaceuticals

  2005cites this paper
• CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

  2005cites this paper
• Site-specific99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain

  2004cites this paper